Laco-cont-200ml (Laco Cont 200ml)
Lacosamide Oral Solution
Product Images NDC 67877-732
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lacosamide Oral Solution (NDC 67877-732). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Laco-cont-465ml (Laco Cont 465ml)
Each milliliter of this solution contains 10 milligrams of lacosamide, which is used to treat seizures. It is important to note that this product contains phenylalanine and the recommended dosage can be found in the package insert. The solution should be stored between 20°C to 25°C (68°F to 77°F) and should not be frozen. Once the bottle is opened, any unused product should be discarded after 6-10 months. This solution is manufactured by Akem Laboratories Ltd. in India and distributed by Ascend Laboratories LLC. in Parsippany, New Jersey.*
Laco-fig-1 (Laco Fig 1)
Laco-fig-2 (Laco Fig 2)
The text describes a figure showing the proportion of patients by responder rate for two groups (LACOSAMIDE and Placebo) in various studies (2, 3, and 1). The chart includes information about improvement, worsening and the percent of patients in each group.*
Laco-structure (Laco Structur)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
